Medical Breakthroughs
AI Device Recalls: Unpacking Post-Market Surveillance Gaps
The rapid proliferation of artificial intelligence in healthcare promises transformative advancements, yet recent data on FDA…
Medical Breakthroughs
Chronic Conditions
Teladoc-Livongo: The $13.7 Billion Impairment & Clinical Validation Gap
The acquisition of Livongo by Teladoc in 2020 for an eye-watering $18.5 billion was heralded as…
Medical Breakthroughs
UnitedHealth AI Lawsuit: Redefining HealthTech’s Regulatory Future
The recent class action lawsuit against UnitedHealth Group (UHG) for alleged algorithmic coverage denials has sent…
Medical Breakthroughs
Triple Aim at 18: Defining Good Healthcare AI for Investors
The article appears to be accurate and up-to-date as of July 16, 2026. The statement “Eighteen…
Medical Breakthroughs
McClellan’s VBC Vision: Fueling Cardiac AI Investment Demand
The trajectory of healthcare AI investment is inextricably linked to the evolving landscape of value-based care…
Medical Breakthroughs
EU AI Act: US Healthcare AI’s Billion Dollar Compliance Challenge
The landscape of healthcare AI investment is undergoing a profound transformation, driven not just by technological…
Medical Breakthroughs
Healthcare AI Failures: The $35 Billion Blunder Pattern
The healthcare AI landscape, while promising, is littered with cautionary tales of ventures that, despite initial…
Preventative Care
AI’s Trillion-Dollar Take: Unlocking Value-Based Care Returns
The US healthcare landscape, a colossal $5.7 trillion market, is undergoing a profound transformation. At its…
Medical Breakthroughs
FDA & CMS: How Regulations Reshaped AI Health Valuations
The regulatory currents shaping the healthcare AI landscape are not merely bureaucratic hurdles; they are powerful…
Medical Breakthroughs
Eric Topol: FDA AI Rules & PCCP for Cardiac AI Investors
The rapid evolution of artificial intelligence in healthcare presents both unprecedented opportunities and complex regulatory challenges.…